| Primary |
| Pneumonia |
20.2% |
| Product Used For Unknown Indication |
16.5% |
| Drug Use For Unknown Indication |
12.8% |
| Infection |
7.3% |
| Bacterial Infection |
5.5% |
| Peritonitis |
5.5% |
| Depression |
3.7% |
| Procedural Pain |
3.7% |
| Fasciotomy |
2.8% |
| Sedation |
2.8% |
| Sepsis |
2.8% |
| Atrial Fibrillation |
1.8% |
| Compartment Syndrome |
1.8% |
| Constipation |
1.8% |
| Diabetes Mellitus |
1.8% |
| Fluid Overload |
1.8% |
| Haemorrhage |
1.8% |
| Interstitial Lung Disease |
1.8% |
| Localised Infection |
1.8% |
| Urinary Tract Infection |
1.8% |
|
| Convulsion |
22.5% |
| Renal Failure |
7.5% |
| Renal Failure Acute |
7.5% |
| Tubulointerstitial Nephritis |
7.5% |
| Liver Function Test Abnormal |
5.0% |
| Mental Status Changes |
5.0% |
| Pyrexia |
5.0% |
| Rash Pruritic |
5.0% |
| Treatment Failure |
5.0% |
| Wound Infection Fungal |
5.0% |
| Acute Generalised Exanthematous Pustulosis |
2.5% |
| Bacteraemia |
2.5% |
| Blood Creatinine Increased |
2.5% |
| Clostridium Difficile Colitis |
2.5% |
| Drug Eruption |
2.5% |
| Enterocolitis |
2.5% |
| Interstitial Lung Disease |
2.5% |
| Mitral Valve Prolapse |
2.5% |
| Multi-organ Failure |
2.5% |
| Off Label Use |
2.5% |
|
| Secondary |
| Product Used For Unknown Indication |
12.6% |
| Acute Promyelocytic Leukaemia |
11.1% |
| Pneumonia |
11.1% |
| Sepsis |
9.6% |
| Bacterial Infection |
8.1% |
| Urinary Tract Infection |
5.6% |
| Acute Tonsillitis |
4.0% |
| Staphylococcal Infection |
4.0% |
| Convulsion |
3.5% |
| Febrile Neutropenia |
3.5% |
| Prophylaxis |
3.5% |
| Abdominal Infection |
3.0% |
| Hidradenitis |
3.0% |
| Osteomyelitis |
3.0% |
| Soft Tissue Infection |
3.0% |
| Acute Lymphocytic Leukaemia |
2.5% |
| Pneumonia Aspiration |
2.5% |
| Depression |
2.0% |
| Epilepsy |
2.0% |
| Interstitial Lung Disease |
2.0% |
|
| Treatment Failure |
22.0% |
| Convulsion |
14.6% |
| Liver Disorder |
7.3% |
| Renal Failure |
7.3% |
| Anticonvulsant Drug Level Decreased |
4.9% |
| Interstitial Lung Disease |
4.9% |
| Rash Pruritic |
4.9% |
| Shock Haemorrhagic |
4.9% |
| Anaemia |
2.4% |
| Anaphylactic Reaction |
2.4% |
| Blood Creatinine Increased |
2.4% |
| Cerebral Thrombosis |
2.4% |
| Condition Aggravated |
2.4% |
| Dermatitis Exfoliative |
2.4% |
| Drug Interaction |
2.4% |
| Enterocolitis |
2.4% |
| Hepatic Function Abnormal |
2.4% |
| Meningitis Fungal |
2.4% |
| Methaemoglobinaemia |
2.4% |
| Neutropenia |
2.4% |
|
| Concomitant |
| Prophylaxis |
22.8% |
| Aplastic Anaemia |
15.8% |
| Product Used For Unknown Indication |
15.3% |
| Drug Use For Unknown Indication |
8.2% |
| Infection Prophylaxis |
6.5% |
| Prophylaxis Against Gastrointestinal Ulcer |
4.5% |
| Antiviral Prophylaxis |
4.1% |
| Anxiety Disorder |
3.0% |
| Constipation |
3.0% |
| Hypertension |
2.6% |
| Infection |
2.3% |
| Insomnia |
2.2% |
| Pain |
1.8% |
| Immunosuppression |
1.3% |
| Non-small Cell Lung Cancer |
1.3% |
| Acute Lymphocytic Leukaemia |
1.2% |
| Antibiotic Therapy |
1.1% |
| Back Pain |
1.0% |
| Fluid Replacement |
1.0% |
| Haemorrhoids |
1.0% |
|
| White Blood Cell Count Decreased |
23.3% |
| Sepsis |
8.2% |
| Pulmonary Embolism |
6.8% |
| Renal Failure |
6.8% |
| Pyrexia |
5.5% |
| Jaundice |
4.1% |
| Scrotal Gangrene |
4.1% |
| Systemic Candida |
4.1% |
| Thrombocytopenia |
4.1% |
| Tooth Extraction |
4.1% |
| White Blood Cell Count Increased |
4.1% |
| Alopecia |
2.7% |
| Appendicitis Perforated |
2.7% |
| Blood Creatinine Increased |
2.7% |
| Cardiac Failure |
2.7% |
| Herpes Zoster |
2.7% |
| Hyperthermia Malignant |
2.7% |
| Pneumonia |
2.7% |
| Proctalgia |
2.7% |
| Respiratory Failure |
2.7% |
|
